Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01774994
Recruitment Status : Completed
First Posted : January 24, 2013
Last Update Posted : January 24, 2013
Sponsor:
Information provided by (Responsible Party):
Maastricht University Medical Center

Brief Summary:
Investigation of arginine and NO metabolism in healthy subjects is important as a reference for alterations in arginine-NO metabolism in patients. Moreover, this study will indicate the changes during aging and gender-related differences. Although data on arginine metabolism exist in literature, data are limited to young healthy male subjects. Since patients with suspected changes in arginine metabolism, e.g. sepsis and cancer patients are often elderly and also women, knowledge of arginine metabolism in these groups is needed.

Condition or disease Intervention/treatment Phase
Healthy Other: stable isotope infusion for measurement of metabolism Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 33 participants
Intervention Model: Single Group Assignment
Primary Purpose: Basic Science
Official Title: Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers
Study Start Date : November 2004
Actual Primary Completion Date : January 2005
Actual Study Completion Date : June 2012

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: stable isotopes
stable isotope infusion for measurement of metabolism
Other: stable isotope infusion for measurement of metabolism



Primary Outcome Measures :
  1. whole body NO synthesis [ Time Frame: 2 hours ]
    postabsorptive nitric oxide synthesis measured by using stable isotope methodology


Secondary Outcome Measures :
  1. whole body protein metabolism [ Time Frame: 2 hours ]
    postabsorptive whole body protein metabolism (protein synthesis, breakdown, net protein breakdown) measured by using stable isotope methodology

  2. whole body arginine metabolism [ Time Frame: 2 hours ]
    postabsorptive arginine metabolism measured by using stable isotope methodology

  3. blood parameters [ Time Frame: 2 hours ]
    postabsorptive blood levels (glucose, insulin, urea, amino acids, CRP)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Written informed consent
  • Age 18-25 years (young); 50-70 years (middle aged/elderly)

Exclusion Criteria:

  • Diabetes mellitus type I
  • Livercirrhosis, pancreatitis, malignancies
  • Hypertension (diastolic blood pressure >95 mmHg or systolic blood pressure >160 mmHg)
  • History of gastrointestinal complaints
  • Recent involuntary weight loss (more than 10 % in 6 months or more than 5 % in one month)
  • Pregnancy (pregnancy test is done in female subjects)
  • Use of medication that can affect arginine metabolism (nitrovasodilators and corticosteroids)
  • Subjects with "high activity level"

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01774994


Sponsors and Collaborators
Maastricht University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Nicolaas E Deutz, MD PhD

Publications:
Layout table for additonal information
Responsible Party: Maastricht University Medical Center
ClinicalTrials.gov Identifier: NCT01774994     History of Changes
Other Study ID Numbers: MEC04-021.3
First Posted: January 24, 2013    Key Record Dates
Last Update Posted: January 24, 2013
Last Verified: January 2013

Keywords provided by Maastricht University Medical Center:
volunteers

Additional relevant MeSH terms:
Layout table for MeSH terms
Nitric Oxide
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Asthmatic Agents
Respiratory System Agents
Free Radical Scavengers
Antioxidants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Endothelium-Dependent Relaxing Factors
Vasodilator Agents
Gasotransmitters
Protective Agents